Treatments & Interventions
Coagulation factor VII
substance
Antihaemophilic factor
substance
Recombinant coagulation factor IX
substance
Porcine antihaemophilic factor agent
substance
Porcine factor VIII
substance
Nonacog alfa
substance
Moroctocog alfa
substance
Simoctocog alfa
substance
Susoctocog alfa
substance
Turoctocog alfa
substance
Lonoctocog alfa
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Prolonged bleeding after dental extraction
Always present (100%)HP:0006298
Reduced factor VII activity
Always present (100%)HP:0008169
Gastrointestinal haemorrhage
Very frequent (80-99%)HP:0002239
Bleeding gums
Frequent (30-79%)HP:0000225
Bruising susceptibility
Frequent (30-79%)HP:0000978
Frequent nosebleeds
Frequent (30-79%)HP:0000421
Hypermenorrhea
Frequent (30-79%)HP:0000132
Joint hemorrhage
Frequent (30-79%)HP:0005261
Low factor II activity
Frequent (30-79%)HP:0008151
Protracted bleeding after surgery
Frequent (30-79%)HP:0004846
Cystic ovaries
Occasional (5-29%)HP:0000138
Post-partum hemorrhage
Occasional (5-29%)HP:0011891
Umbilical cord issue
Occasional (5-29%)HP:0010881
Bleeding tendency
HP:0001892
Intracranial haemorrhage
HP:0002170
Intramuscular haematoma
HP:0012233
Quick Facts
- SNOMED CT
- 37193007
- UMLS CUI
- C0015503
- Fully Specified Name
- Factor VII deficiency (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 16
- Known Treatments
- 11
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.